← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Symbiotix Biotherapies, Inc.
Brookline, MA
$4,957,834
Total funding
4
Grants
Funding over time
peak $2.3M · FY2014–16$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
Funding mix
By agency
NIH$4,957,834 · 4
By mechanism
R42$4,238,112 · 2
R41$719,722 · 2
Investigators at Symbiotix Biotherapies, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Novel commensal polysaccharide treats multiple sclerosis through Treg modulation$2,264,726
R42 · FY2015 · AI
Therapeutics for inflammatory bowel disease from the microbiome$1,973,386
R42 · FY2016 · DK
Therapeutics for inflammatory bowel disease from the microbiome$396,794
R41 · FY2014 · DK
Novel commensal polysaccharide treats multiple sclerosis through Treg modulation$322,928
R41 · FY2014 · AI